As the major effector cells that process anti-tumour surveillance in cancer patients, CD8+ cytotoxic T cells were mainly compromised and exhausted by the oncogenic factors in the tumour microenvironment, with a sign of less proliferation, blunt activation and reduced expression of anti-tumour cytokines [27]. Here, CD8A is linked to cancer.